Jane Street’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-84,778
| Closed | -$2.87M | – | 12737 |
|
|
2025
Q4 | $2.87M | Buy |
+84,778
| New | +$2.63M | ﹤0.01% | 4118 |
|
|
2025
Q1 | – | Sell |
-4,587
| Closed | -$58K | – | 10408 |
|
|
2024
Q4 | $58K | Sell |
4,587
-3,727
| -45% | -$47.3K | ﹤0.01% | 8931 |
|
|
2024
Q3 | $134K | Sell |
8,314
-16,813
| -67% | -$340K | ﹤0.01% | 8864 |
|
|
2024
Q2 | $613K | Buy |
25,127
+10,031
| +66% | +$463K | ﹤0.01% | 6687 |
|
|
2024
Q1 | $1.08M | Buy |
15,096
+5,549
| +58% | +$771K | ﹤0.01% | 5265 |
|
|
2023
Q4 | $1.9M | Buy |
9,547
+4,226
| +79% | +$523K | ﹤0.01% | 4411 |
|
|
2023
Q3 | $708K | Buy |
5,321
+2,968
| +126% | +$484K | ﹤0.01% | 5711 |
|
|
2023
Q2 | $352K | Sell |
2,353
-3,204
| -58% | -$499K | ﹤0.01% | 6879 |
|
|
2023
Q1 | $816K | Buy |
+5,557
| New | +$1.12M | ﹤0.01% | 5404 |
|
|
2020
Q3 | – | Sell |
-1,231
| Closed | -$285K | – | 7782 |
|
|
2020
Q2 | $285K | Buy |
+1,231
| New | +$190K | ﹤0.01% | 5913 |
|
Jane Street's RAPT Position: Q1 2026 in Review
Jane Street sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 84,778 shares — an estimated $2.87M sold.
Jane Street first reported a position in RAPT in Q2 2020 and held it in 10 quarters. The position peaked at $2.87M in Q4 2025. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.
- Jane Street reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
- Jane Street sold 84,778 RAPT Therapeutics shares in Q1 2026, an estimated $2.87M.
- Jane Street first reported a position in RAPT Therapeutics in Q2 2020 and held it in 10 quarters.
- Jane Street's RAPT Therapeutics position peaked at $2.87M in Q4 2025.
- 0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.